The Firm represented Barclays Capital Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as dealer managers and solicitation agents, in connection with exchange offers and related consent solicitations by CVS Health Corporation (“CVS Health”), in which CVS Health offered to exchange 4.75% Senior Notes due 2022 and 5% Senior Notes due 2024 (the “Omnicare Notes”), issued by Omnicare, Inc., a company recently acquired by CVS Health, for new 4.75% Senior Notes due 2022 and 5% Senior Notes due 2024 issued by CVS Health and cash. Concurrently with the exchange offers, CVS Health solicited consents to amend the indentures governing the Omnicare Notes.
CVS Health is an integrated pharmacy healthcare company. CVS Health currently has three reportable segments: Pharmacy Services, consisting of a full range of pharmacy benefit management services; Retail Pharmacy, selling prescription drugs and a wide assortment of general merchandise; and Corporate, providing management and administrative services to support CVS Health.
The Simpson Thacher team included John Lobrano, Ryan Bekkerus, Hui Lin, Kai Fan and Elliott Im (Capital Markets); Jonathan Cantor and Taylor Alexander (Tax); Jeanne Annarumma (ECEB); and Jennie Getsin (Blue Sky).